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Abstract
Small fiber neuropathy is a painful sensory nervous system disorder characterized by damage to unmyelinated C- and thinly
myelinated Ad- nerve fibers, clinically manifested by burning pain in the distal extremities and dysautonomia. The clinical
onset in adulthood suggests a time-dependent process. The mechanisms that underlie nerve fiber injury in small fiber
neuropathy are incompletely understood, although roles for energetic stress have been suggested. In the present study,
we report time-dependent degeneration of neurites from dorsal root ganglia neurons in culture expressing small fiber
neuropathy-associated G856D mutant Nav1.7 channels and demonstrate a time-dependent increase in intracellular calcium
levels [Ca2þ]i and reactive oxygen species, together with a decrease in ATP levels. Together with a previous clinical report of
burning pain in the feet and hands associated with reduced levels of Naþ/Kþ-ATPase in humans with high altitude sickness,
the present results link energetic stress and reactive oxygen species production with the development of a painful neuropathy
that preferentially affects small-diameter axons.
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Introduction
Small ﬁber neuropathy (SFN) is characterized by injury
to unmyelinated C-ﬁbers and thinly myelinated Ad-ﬁbers
and a loss of small-diameter intra-epidermal nerve ﬁbers
(IENF), producing sensory and autonomic abnormal-
ities.1–4 SFN can occur as an accompaniment of multiple
conditions, including diabetes mellitus and impaired glu-
cose tolerance, systemic immune-mediated diseases,
cancer chemotherapy, and infectious processes, but in
24%–93% of cases of SFN, there is no apparent non-
genetic cause.5,6 Faber et al.7 reported gain-of-function
mutations in voltage-gated sodium channel Nav1.7
(SCN9A) in nearly 30% of patients with idiopathic
biopsy-conﬁrmed, painful SFN. Subsequently,
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additional SFN-associated gain-of-function mutations
have been identiﬁed in SCN9A,8,9 in SCN10A (the
gene encoding Nav1.8),10–12 and SCN11A (the gene
encoding Nav1.9).13,14
Nav1.7 mutation G856D (c.2567G>A) was identiﬁed
in a multi-generational family whose aﬀected members
experience SFN-associated symptoms, including severe
pain in the distal extremities.9 Functional analyses demon-
strated that the G856D mutation signiﬁcantly alters the
biophysical properties of the Nav1.7 channel, producing
hyperpolarization of activation, depolarization of steady-
state fast inactivation, slow deactivation, and markedly
enhanced persistent current.9 The altered biophysical
properties of the mutant Nav1.7 channel depolarize
dorsal root ganglia (DRG) neurons and make them
hyperexcitable, as manifested by reduced current thresh-
old, increased frequency of ﬁring in response to subthres-
hold stimulation, and increased spontaneous ﬁring.
In contrast to neurites of DRG neurons expressing
wild-type (WT) Nav1.7 channels, neurites of DRG neu-
rons expressing mutant G856D channels display sub-
stantial degeneration when pre-conditioned in vitro by
depolarization and metabolic challenge.15 Previous
work in small-diameter white matter axons subjected to
anoxia has shown that increased inward Naþ ﬂux
through incompletely inactivating sodium channels can
lead to reversal of the sodium-calcium exchanger (NCX)
and import of damaging levels of Ca2þ.16 Estacion
et al.15 recently showed that the increased levels of
[Ca2þ]i in G856D-expressing neurites results from
enhanced Naþ inﬂux through mutant Nav1.7 channels
and reverse operation of the NCX. Increased levels of
intracellular [Ca2þ] have been linked to initiation of
degradative pathways and axonal degeneration through
activation of calpains, phospholipases, and nitric acid
synthases (see literature17).
In humans, SFN generally progresses in an age-depen-
dent manner18 with symptoms usually appearing at least a
decade after birth, despite the presence throughout life of
gain-of-function mutations of sodium channels.7,10,13
These observations suggest that enhanced Naþ inﬂux
through mutant Nav1.7 channels may confer an accumu-
lating energetic burden on axons, particularly on
small-diameter unmyelinated axons (i.e. IENF), which
are preferentially sensitive to small changes in ion channel
activity due to their high surface-to-volume ratio, high
input resistance, and short diﬀusional and electrotonic
length constant.19,20 In this study, we assayed time-depen-
dent changes in intracellular [Ca2þ]i levels, degeneration
and energetic stress in the neurites of DRG neurons
expressing mutant G856D Nav1.7 channels. Our results
provide mechanistic evidence for a time-dependent
increase in intracellular [Ca2þ]i and energetic compromise
in the neurites of DRG neurons expressing G856D
mutant channels.
Materials and methods
Expression constructs
The expression constructs for WT and G856D mutant
forms of human Nav1.7 pore-forming a- subunit (adult
isoform containing exon 5) have been described previ-
ously.9 The functional activity of the clones used in this
study was conﬁrmed by electrophysiology on transfected
HEK cells.
Isolation and culture of primary DRG neurons
All animal protocols were approved by the Institutional
Animal Care and Use Committee of the VA Connecticut
Healthcare System, and all experiments were carried out
in accordance with guidelines for the care and use of
laboratory animals from National Institutes of Health.
Isolation and culture of DRG neurons were performed
as described previously,15 with slight modiﬁcations.
Brieﬂy, 4–6-week-old male Sprague-Dawley rats
(Charles River, USA) were anesthetized with CO2 nar-
cosis and decapitated; 14 DRG from each animal were
surgically removed and placed in ice-cold complete saline
solution (CSS; containing 137mM NaCl, 5.3mM KCl,
1mM MgCl2, 25mM Sorbitol, 3mM CaCl2, and 10mM
HEPES; pH 7.2, osmolarity 315mOsm/L). DRG were
pooled from two animals and after careful removal of
meninges were enzymatically digested with Collagenase
A ((70474031, Roche) 1.5mg/ml in CSS containing
0.6mM ethylene diamine tetraacetic acid) for 15min at
37C with mild agitation, followed by Collagenase D
((70507821, Roche) 1.5mg/ml in CSS, containing
30U/ml Papain (LS003126, Worthington Biochemical)
and 0.6mM ethylene diamine tetraacetic acid) for
15min at 37C with mild agitation. Digested ganglia
were gently triturated in two steps with wide-bore pipette
tips (T-205-WB-C-R-S, Axygen) in 500 ml DRG media
(DMEM/F12 (11320, Gibco) supplemented with
100U/ml penicillin, 0.1mg/ml streptomycin, and 10%
fetal bovine serum (SH3008, HyClone) containing
1.5mg/ml trypsin inhibitor (T9253, Sigma) and 1.5mg/
ml bovine serum albumin (BSA; A8806, Sigma). The
triturated cell suspension was layered over 5ml of 15%
BSA (A9418, Sigma) in DRG media to form a gradient
and centrifuged at 200 relative centrifugal force for
10min to remove the non-neuronal cells.21 The neuron-
enriched cell pellet was re-suspended in 40 ml transfection
reagent (Amaxa, Basic Neuron SCN Nucleofector kit,
VSPI-1003, Lonza) to permit electroporation.
Transfection of DRG neurons
After enrichment, the dissociated DRG neurons were
transfected by electroporation with the WT and
G856D mutant Nav1.7 expression constructs along
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with either enhanced green ﬂuorescent protein (GFP) or
mCherry (mCh) as a ﬂuorescent reporter, using the
nucleofector II system (program 6, Amaxa). After re-
suspending the cells in transfection reagent, the cell sus-
pension was split into two equal volumes of 20 ml and 2 ml
of Nav1.7 construct DNA (stock 1 mg/ml), and 0.2 ml of
marker DNA (stock 0.5 mg/ml) was mixed (Nav1.7 to
marker ratio 20:1). After electroporation, cells were
allowed to recover for 10min at 37C in 0.2ml of pre-
warmed Ca2þ free DMEM (21068, Gibco). The cell sus-
pension was added with 1.2ml of pre-warmed DRG
media containing 1.5mg/ml trypsin inhibitor and
1.5mg/ml BSA; 100 ml of this cell suspension was
plated on 14mm laminin-coated (L2020, Sigma) and
poly-d-lysine pre-coated glass bottom dishes (P35GC-
1.5-14-C, MatTek Corp.) in a circular ‘‘donut’’ forming
distribution (donut culture) and incubated at 37C and
5% CO2. One hour later, 1.0ml of DRG media supple-
mented with 50 ng/ml NGF (N-240, Alomone Labs) and
50 ng/ml GDNF (450-10, Peprotech) was gently added,
and cells were maintained at 37C in a 5% CO2 incuba-
tor. The following day, DRG media was replaced with
neurobasal A medium (A1371001, Gibco) containing
100U/ml penicillin, 0.1mg/ml streptomycin, 2.5mM
l-glutamine, 1X B27 supplement (17504, Gibco), and
50 ng/ml of NGF and GDNF. To inhibit the growth of
non-neuronal cells, anti-mitotic reagent 5-ﬂuoro-20-deox-
yuridine (F0503, Sigma) and uridine (U30003, Sigma)
were added in the culture media at a concentration
of 10 mM each for one week and thereafter at a
lower concentration of 1 mM. The culture media was
changed every week, and throughout the experiment,
cells were kept at 37C and 5% CO2 inside a humidiﬁed
incubator. For determining the viability of transfected
DRG neurons, Live-Dead assay kit (R37601,
Molecular Probes) was used as per manufacture recom-
mended guidelines.
Donut culture of DRG neurons
Figure 1 illustrates the seeding methods and distribution
of DRG neurons on the laminin-coated and poly-d-
lysine pre-coated glass culture surface. The standard
dispersed seeding method for culturing DRG neurons
usually leads to clustering, especially towards the center
of the coated coverslip. The formation of neurites (both
density and length) is aﬀected by clustering behavior;
while neurons in a cluster grow neurites extensively, the
distantly isolated neurons do not (data not shown). The
donut seeding method, which involves plating cells in
donut-like distribution leaving a small void at the
center, provides a uniform distribution of DRG neurons
on the culture surface and improves neurite formation as
well as quantiﬁcation by the neurite tracer plugin in
Image J.
Live cell imaging
Imaging was performed on live DRG neurons on mul-
tiple days in culture (days in vitro (DIV)), using Nikon
Eclipse Ti microscopes ﬁtted with environmentally con-
trolled chambers (InVivo Scientiﬁc, St Louis, MO) to
maintain cells at 37C temperature and 5% CO2 inside
a humidiﬁed environment. Images were acquired using
NIS-Elements software (Nikon). For all imaging pur-
poses, phenol red-free Neurobasal A medium was used
(12349015, Gibco).
Neurite analysis
For quantiﬁcation of neurite lengths, large-ﬁeld montage
images covering the entire culture area of the glass
bottom dish were acquired using a motorized stage and
20 objective of live DRG neuronal cultures. For image
processing and neurite length measurements,
NeuriteTracer plugin was used in Image J (version
1.48, National Institutes of Health, Bethesda, MD).22
Images were converted to binary, and threshold levels
were set based on GFP signal intensity to create two
binary images, one including cell bodies as well as neur-
ites (neuronal) and another only cell bodies (nuclear).
For each montage image, total neurite length was calcu-
lated and divided by the total number of neurons, which
were counted separately using the particle analyzer
module in Image J. In each experiment, neurite lengths
for cells expressing the mutant G856D channel were nor-
malized and expressed as a percentage of the length for
sister cultures containing WT-expressing DRG neurons,
prepared concurrently from the same preparation of
DRGs. For each time point, one large image from a
single culture dish (5–8 dishes per culture) was analyzed
from at least three diﬀerent cultures. For quantiﬁcation
of degenerating neurites transfected with Nav1.7 WT
and G856D constructs, neurite segments were considered
degenerating if they displayed signs of fragmentation
and/or repetitive blebbing and were counted visually as
a percentage to the total GFP-expressing neurites in the
image. Four to ﬁve images at 40 magniﬁcation were
acquired and analyzed from random areas spanning
the entire culture dish, and at least three to ﬁve dishes
were analyzed from three diﬀerent cultures.
Intracellular calcium imaging
Intracellular calcium levels [Ca2þ]i were measured using
the cell permeable, acetoxymethyl ester (AM) derivative
of the ratio-metric calcium indicator fura2 (F1221,
Molecular Probes). DRG neurons cultured for 3, 15,
and 30 DIV were loaded with 2 mM fura2-AM and
0.02% Pluronic detergent (540025, Calbiochem) in
standard bath solution (SBS; containing 140mM NaCl,
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3mM KCl, 1mM MgCl2, 1mM CaCl2, and 10mM
HEPES; pH 7.2, osmolarity 310mOsm/L) and incubated
for 45min at 37C inside a 5% CO2 incubator. After
gentle washing with SBS and another 30min incubation,
images were acquired from live cells. Transfected neur-
ites were identiﬁed by expression of mCherry, which was
co-transfected with Nav1.7 WT or G6856D constructs.
Cultures were alternatively illuminated every 200ms with
340 nm and 380 nm wavelength light from a fast switch-
ing xenon light source (Lambda DG-4, Sutter
Instruments). Images were acquired using a Nikon Ti-
E inverted microscope equipped with a QuantEM CCD
camera (Princeton Instruments) and a UV permissive
objective (Super Fluor, Nikon). Intracellular calcium
levels [Ca2þ]i were measured as a ratio of ﬂuorescence
signal at 340 nm and 380 nm (F340/F380) excitation wave-
lengths after background subtraction by overlaying
neuronal cell bodies and neurites with deﬁned regions
of interest (ROI) markers, using NIS-Elements software
(Nikon). Thin and thick neurites were deﬁned by their
diameters (thin neurites< 3mm, thick neurites> 5mm)
and identiﬁed by overlaying with a size marker.
Intracellular ATP analysis
Assessment of neurite ATP levels was performed by uti-
lizing a cell permeable AM ester derivative of magnesium
green (MgGreen) as an indicator dye (M3735, Molecular
Probes). ATP binds to magnesium with higher aﬃnity
than ADP, and cytosolic magnesium concentration
[Mg2þ]i rises upon ATP hydrolysis. Based on this prin-
ciple, intracellular ATP levels have been previously mea-
sured in inverse correlation with [Mg2þ]i levels.
23 Brieﬂy,
cells were loaded with 1 mM MgGreen-AM and 0.02%
Figure 1. Culture of primary rat DRG neurons. Representative images describing the seeding methods and distribution of DRG neurons
on the coated glass culture surface. (a) The standard method of seeding cells often leads to clustering of DRG neurons in culture. The
middle image shows that formation of neurites (both density and length) is affected by the clustering behavior. Neurons in a cluster can
grow extensive neurites (boxed area, enlarged on right), while isolated neurons generally do not (arrow). This distribution of neurons can
result in experimental variability and an inability to process images for neurite quantification. (b) The donut seeding method plates DRG
neurons in a ‘‘donut-like’’ pattern and leaves a small void at the center of the culture surface (indicated by the small circle). This manner of
plating provides a uniform distribution of DRG neurons on the coated culture surface. Phase contrast (middle panel) and GFP fluorescent
signal (right panel) images of transfected neurons and neurites of the same culture dish are shown. Note the differences in distribution of
neurons and neurite formation displayed by the standard method and donut-like method of plating.
GFP: green fluorescent protein; DIV: days in vitro.
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Pluronic detergent in phenol red-free growth media and
incubated for 1 hr at 37C inside a 5% CO2 incubator,
followed by gentle washing and another 30min incuba-
tion inside the incubator. Intracellular ATP levels were
assessed in inverse correlation to MgGreen ﬂuorescence
intensity after background correction by overlaying
neurites with deﬁned ROI markers using NIS-Elements
software.
Analysis for reactive oxygen species
Reactive oxygen species (ROS) were measured with the
general oxidative stress indicator dye CM-H2DCFDA
(C6827, Molecular Probes), which is suitable for intra-
cellular measurements of ROS. CM-H2DCFDA is oxi-
dized by ROS, and the oxidized product produces
intense green ﬂuorescence. Brieﬂy, DRG neurons cul-
tured for 3, 15, and 30 DIV were loaded with 5 mM
CM-H2DCFDA and 0.02% Pluronic detergent in
phenol red-free culture media and incubated for 30min
at 37C inside a 5% CO2 incubator, followed by gentle
washing and imaging. Intracellular ROS levels were
assessed in direct correlation to the ﬂuorescence intensity
after background correction and measured by overlaying
neurites with deﬁned ROI markers using NIS-Elements
software.
Statistical analysis
All results are expressed as mean values SEM from a
set of replicate experiments at each time point.
Comparison between WT and G856D was analyzed by
unpaired Student’s t test with unequal variance, and P
values less than 0.05 were considered statistically
signiﬁcant.
Results
Time-dependent decrease in lengths of neurites
expressing the SFN-associated G856D Nav1.7
mutant channels
SFN is generally associated with a loss of small caliber
IENF.1 To determine the eﬀect of Nav1.7 mutant chan-
nels on the neurites of DRG neurons, we expressed WT
and G856D mutant Nav1.7 channels in DRG neurons
in vitro and compared the neurite lengths after three days
in culture. At three DIV, the average neurite length of
DRG neurons expressing G856D mutant Nav1.7 chan-
nels was 97.46 6.22% relative to 100 3.92% for the
WT Nav1.7 channels (P¼ ns, Figure 2(a) and (c)).
SFN is characterized by age-dependent disease pro-
gression. Therefore, we also compared neurite lengths
from DRG neurons expressing the WT and G856D
mutant Nav1.7 channels at a later time point of 30
DIV culture. At 30 DIV, the average neurite length
from DRG neurons expressing the G856D mutant
Nav1.7 was 70.54 3.33% relative to 100 2.31% for
the WT Nav1.7 (P< 0.001, Figure 2(a) and (c)), indicat-
ing a time-dependent decrease in neurite lengths express-
ing G856D mutant channels.
Time-dependent degeneration of small-diameter
neurites expressing G856D mutant Nav1.7 channels
To examine molecular pathways that contribute to the
time-dependent decrease in neurite lengths of G856D/
Nav1.7-expressing DRG neurons, we quantiﬁed the fre-
quency of degenerating neurites of DRG neuron cul-
tures, expressing the WT and G856D mutant Nav1.7
channels. The average frequency of degenerating neurites
of DRG neurons at three days in culture was
1.52 0.33% for WT Nav1.7 and 1.60 0.29% for the
G856D mutant Nav1.7 channels (P¼ ns, Figure 2(a) and
(d)). At 30 days in culture, the average frequency of
degenerating neurites from DRG neurons expressing
WT Nav1.7 was 11.57 0.59% in comparison to
30.92 1.78% for DRG neurons expressing G856D
mutant Nav1.7 channels (P< 0.001, Figure 2(a) and
(d)). Moreover, thin (<3 mm diameter) neurites exhibited
a nearly four-fold greater percentage of degenerating
neurites than thick (>5 mm diameter) neurites (Figure
2(f); thin: 78.12% vs. thick: 21.88%). The signiﬁcant
increase in the frequency of degenerating neurites from
DRG neurons expressing the G856D mutant Nav1.7
channels and maintained for 30 DIV suggests that the
expression of the G856D mutant channel can lead to
degeneration of neurites in vitro in a time-dependent
manner.
These results demonstrate time-dependent develop-
ment of axonal injury in DRG neurons expressing
G856D channels. To rule out the possibility that this
was due to degeneration of DRG neurons, we assessed
DRG neurons using a live/dead cell assay. The signiﬁ-
cant decrease in neurite lengths and increase in frequency
of degenerating neurites were not associated with a
decrease in viability of neurons expressing the G856D
mutant Nav1.7 channels (Figure 2(e)).
Elevated intracellular calcium levels in small-diameter
neurites expressing G856D Nav1.7mutant channels
To determine whether neuronal cell bodies and neurites
exhibit diﬀerential levels of [Ca2þ]i, we compared [Ca
2þ]i
levels from healthy appearing neurites that did not show
signs of degeneration and also cell bodies of the DRG
neurons expressing WT and G856D mutant Nav1.7
channels at diﬀerent times in culture. By using the ratio-
metric calcium indicator fura2, we observed signiﬁcantly
higher levels of [Ca2þ]i in small-diameter neurites
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Figure 2. Neurite degeneration in DRG neurons expressing WT and mutant G856D Nav1.7 channels. Representative images of DRG
neurons expressing wild type (WT) (a) and G856D mutant (b) Nav1.7 channels and GFP at three days (left panel) and 30 days (middle
panel) in vitro. Images on right panels show WT and G856D expressing neurites at 30 days in culture at increased magnification. Arrows
denote signs of degeneration (blebbing and fragmentation) in small-diameter (<3 mm) neurites expressing G856D; in contrast, larger
diameter (>5 mm) neurites expressing G856D are relatively unaffected (arrowheads). Small and larger diameter neurites expressing WT
Nav1.7 channels exhibit limited degeneration. (c) Histograms showing neurite length (average length relative to WT control) of DRG
neurons expressing the WTand G856D mutant Nav1.7 channels at three days and 30 days in vitro. Note the reduction in neurite lengths of
DRG neurons expressing the G856D mutant at 30 days in culture compared to WT channels. (d) Histograms showing frequency of
degenerating neurites expressing WT and G856D Nav1.7 channels after three days and 30 days in vitro. The frequency of degenerating
neurites was low and not significantly different between WTand G856D expressing neurons at three days in culture. In contrast, at 30 days
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(<3.0 mm; thin) expressing G856D mutant Nav1.7 chan-
nels at 30 DIV as compared to thin diameter neurites
expressing WT Nav1.7 channels (P¼ 0.0082,
Figure 3(c)). In contrast, at 30 DIV, thick neurites
(>5.0 mm in diameter) and neuronal cell bodies express-
ing the WT and G856D Nav1.7 channels did not exhibit
signiﬁcant diﬀerences in [Ca2þ]i levels (Figure 3(c)).
Speciﬁcally, at three DIV, signiﬁcant diﬀerences in
[Ca2þ]i levels in the neurites of either< 3.0mm
or> 5.0 mm diameter were not detected (Figure 3(b)).
At three days, the average ﬂuorescence intensity ratio
of fura2 (F340/F380) of neurites< 3.0 mm diameter (thin)
was 0.8401 0.0256 for WT Nav1.7 and 0.8732 0.0439
for G856D Nav1.7 (P¼ 0.5333, Figure 3(b)), and for
Figure 3. Intracellular calcium levels in neurites expressing WT and G856D Nav1.7 channels. (a) A representative image showing the
ratio of fura2 emission signals at 340 nm and 380 nm excitation wavelengths (F340/F380) of DRG neurons at 30 days in vitro. The color bar
denotes the F340/F380 values (0–2), with higher levels of [Ca
2þ]i indicated at the far red end of the spectrum. Arrowheads point to larger
diameter neurites that are color-coded towards the blue end of the spectrum (lower [Ca2þ]i levels), and arrows point to the smaller
diameter neurites that are color-coded towards the red end of the spectrum (higher [Ca2þ]i levels). (b) and (c) Histograms showing the
average F340/F380 values of neurites transfected with WT and G856D mutant Nav1.7 channels or neurites in the cultures that are
untransfected after three days (b) and 30 days (c) in vitro. Thin and thick neurites are defined as< 3mm or> 5mm in diameter, respectively.
Significant differences were not observed between any groups of neurites at three days in culture. In contrast, at 30 days in vitro, [Ca2þ]i
levels (assayed by F340/F380 values) were significantly higher in thin neurites expressing the G856D mutant Nav1.7 in comparison to the WT
Nav1.7 expressing neurites (P¼ 0.0082). The F340/F380 values were not significantly different between thick neurites expressing WT and
G856D channels or between neuronal cell bodies expressing WT and G856D channels.
Figure 2. Continued
in culture, the frequency of degenerating neurites was approximately three-fold greater in neurons expressing G856D in comparison to
WT channels. (e) Histogram showing Live/Dead assay viability of WT and G856D transfected DRG neurons at 30 days in culture.
Approximately 95% of both WTand G856D expressing neurons were viable at 30 days in vitro. (f) Histogram of degeneration of G856D-
expressing thin and thick neurites at 30 days in culture. Note that degeneration occurs significantly more frequently in small-diameter
(<3mm) compared to large-diameter (>5mm) neurites.
GFP: green fluorescent protein; DIV: days in vitro.
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Figure 4. ATP levels in neurites expressing WT and G856D Nav1.7 channels. (a) Representative images showing the WT and G856D
expressing neurites and co-transfected with mCherry reporter (red) and assayed with Magnesium Green, AM, fluorescence (green) of
DRG neurons at three days (upper panels) and 30 days (lower panels) in vitro. MgGreen fluorescence inversely correlates with ATP levels.
8 Molecular Pain
neurites> 5.0mm in diameter (thick), the average F340/
F380 value was 0.7922 0.0319 for WT Nav1.7 and
0.7662 0.0308 for G856D mutant Nav1.7 (P¼ 0.5887,
Figure 3(b)). At 30 DIV, the average F340/F380 value for
thin neurites was 0.8257 0.0263 for WT Nav1.7 and
0.9525 0.0194 for G856D mutant Nav1.7 (P¼ 0.0082,
Figure 3(c)), while for thick neurites, the average F340/
F380 value was 0.6598 0.0443 for WT Nav1.7 and
0.6461 0.0728)for G856D mutant Nav1.7 (P¼ 0.8801,
Figure 3(c)). Diﬀerences in F340/F380 values were not sig-
niﬁcant for neuronal cell bodies that were either trans-
fected or nontransfected with WT or G856D constructs
(Figure 3(c)).
Time-dependent decrease in ATP levels in neurites
expressing G856D Nav1.7 mutant channels
Previous studies have linked neurite injury due to Naþ/
Kþ-ATPase run-down with sodium channel activity in
an in vitro model of mitochondrial compromise in
DRG neurons.21 However, ATP levels have not been
assessed in painful neuropathy due to Nav1.7 mutations.
Utilizing MgGreen as an indicator, with ﬂuorescence
intensity that inversely correlates with ATP levels, we
assayed ATP levels from healthy appearing neurites
(with no signs of degeneration) from WT and G856D-
expressing DRG neurons. At 3 and 15 DIV, the average
values for MgGreen ﬂuorescence were not signiﬁcantly
diﬀerent between WT and G856D expressing neurites (3
days: WT thin¼ 1484 652, G856D thin¼ 1160 767;
WT thick¼ 2370 1888, G856D thick¼ 217 159; 15
days: WT thin¼ 1593 502, G856D thin¼ 6975 6249;
WT thick¼ 5624 2927, G856D thick¼ 11057 7120;
P¼ns for both thin and thick neurites, Figure 4(a) and
(b)). In contrast, at 30 DIV, the average value of
MgGreen ﬂuorescence was signiﬁcantly greater in neur-
ites (both thin and thick) expressing G856D mutant
channels in comparison to neurites expressing WT chan-
nels (30 days: WT thin¼ 6939 2648, G856D thin
25100 4068, WT thick¼ 12756 3535, G856D
thick¼ 36239 4369; P¼ 0.0096 for thin and
P¼ 0.0058 for thick neurites, Figure 4(a) and (b)), indi-
cating lower levels of ATP in G856D expressing neurites
as compared to WT expressing neurites.
Elevated ROS level in neurites expressing G856D
Nav1.7 channels
We next measured ROS levels from healthy appearing
neurites by utilizing a cell permeable variant of the gen-
eral oxidative stress indicator CM-H2DCFDA, which
after oxidation by ROS produces green ﬂuorescence. In
parallel to the results of ATP analysis, the CM-
H2DCFDA ﬂuorescence values between WT and
G856D expressing neurites were not signiﬁcantly diﬀer-
ent at 3 and 15 DIV (3 days: WT thin 2381 2639,
G856D thin¼ 1452 989; WT thick¼ 1085 977,
G856D thick¼ 1540 1319; 15 days: WT thin
198 233, G856D thin¼ 335 484; WT
thick¼ 9174 7720, G856D thick¼ 1012 1579; P¼ns
for both thin and thick neurites, Figure 5(a) and (b)). At
30 days in culture, the CM-H2DCFDA ﬂuorescence was
signiﬁcantly greater in neurites (both thin and thick)
expressing G856D mutant channels as compared to
neurites expressing WT channels (30 days: WT
thin¼ 19014 4304, G856D thin¼ 72421 18000; WT
thick¼ 18942 5160, G856D thick¼ 82828 21064;
Figure 5(a) and(b)).
Discussion
SFN is a disorder associated with injury to peripheral
unmyelinated C-ﬁbers and thinly myelinated Ad-ﬁbers
and loss of IENF and is clinically characterized by burn-
ing pain and dysautonomia.1,2,4,24,25 Although SFN
often occurs in the context of underlying disorders that
include diabetes mellitus, impaired glucose tolerance,
HIV infection, cancer chemotherapy, and other systemic
diseases, in a substantial percentage of patients SFN
occurs in the absence of an identiﬁable non-genetic
cause.2,3,5,7 Faber et al.7 recently reported gain-of-func-
tion mutations in SCN9A (the gene encoding sodium
channel Nav1.7) in nearly 30% of patients meeting strin-
gent criteria for idiopathic SFN. Subsequently, add-
itional gain-of-function mutations in SCN9A have been
identiﬁed in patients with idiopathic SFN.8,26 Gain-of-
function mutations have also been identiﬁed in SCN10A
(the gene encoding Nav1.8)10–12 and SCN11A (the gene
encoding Nav1.9)13,14 in patients with idiopathic SFN.
Figure 4. Continued
Small arrowheads indicate transfected neurites with low MgGreen fluorescence, large arrowheads point to untransfected neurites with
high MgGreen fluorescence, and arrows point to degenerating transfected neurites with high MgGreen fluorescence. The asterisk marks a
G856D expressing neurite that does not exhibit signs of degeneration. Note the increased frequency of neurites with a high MgGreen
signal at 30 days in culture that express G856D compared to WTexpressing neurites, or to WTand G856D expressing neurites at three
days in culture. (b) Histogram showing the average values of MgGreen fluorescence at 3 days, 15 days, and 30 days in vitro of thin (<3.0 mm)
and thick (>5.0 mm) neurites expressing WT and G856D channels. MgGreen flurorescence is low, and differences are not statistically
significant betweenWTand G856D expressing neurites at 3 days and 15 days. In contrast, at 30 days in culture, both thin and thick neurites
expressing G856D Nav1.7 exhibit significantly higher MgGreen fluorescence levels in comparison to neurites expressing WT Nav1.7
(P¼ 0.0096 for thin and P¼ 0.0058 for thick nerve fibers).
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Figure 5. Oxidative stress in neurites expressing Nav1.7. (a) Representative images showing WT and G856D expressing neurites co-
transfected with mCherry reporter (red) and labeled with CM-H2DCFDA (green) from DRG neurons at three days (upper panel) and 30
days (lower panel) in vitro. Small arrowheads point to transfected neurites with low fluorescence for CM-H2DCFDA, large arrowheads
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However, molecular pathways that lead to degeneration
in axons expressing gain-of-function mutations of
sodium channels are incompletely understood, and the
predilection for small-diameter axons has remained
enigmatic.
Mutation G856D (c.2567G>A) in sodium channel
Nav1.7, identiﬁed in SFN-aﬀected individuals in a
multi-generation family,9 produces robust alterations of
Nav1.7 channel biophysical properties when expressed in
rat DRG neurons, hyperpolarizing channel activation by
10–15mV, depolarizing voltage dependence of steady-
state fast inactivation by 6.2mV, slowing deactivation,
and markedly enhancing ramp current and persistent
current.9 Current clamp analyses demonstrate a depolar-
ized resting membrane potential and indicate that DRG
neurons expressing G856D mutant channels are hyper-
excitable, exhibiting decreased current threshold and
increased spontaneous ﬁring.9
To identify pathways that contribute to axonal dys-
function due to the G856D Nav1.7 mutation, we utilized
an in vitro model system in which DRG neurons are
transfected with WT or G856D Nav1.7 constructs.
Using this in vitro model, we previously demonstrated
that expression of another SFN-associated Nav1.7
mutant channel, I228M, signiﬁcantly reduces mean neur-
ite length at three days in culture.27 In contrast, in the
present study, mean neurite lengths of DRG neurons
transfected with mutant G856D Nav1.7 constructs
were not signiﬁcantly diﬀerent at three days in culture.
However, there was a time-dependent reduction in the
length of G856D-expressing neurites compared to WT
neurites, with the mean neurite lengths of G856D-expres-
sing neurons displaying a nearly 30% decrease compared
to WT neurites at 30 days in culture. Paralleling the
reduction in neurite lengths of G856D-expressing neu-
rons, we observed a signiﬁcantly increased percentage
of neurites displaying signs of degeneration at 30 days.
These observations in tissue culture suggest that the pres-
ence of mutant G856D Nav1.7 channels contributes in a
time-dependent manner to dysfunction of neurite integ-
rity. The time-dependent but relatively rapid time-course
that we observed in vitro may have a clinical correlate.
Although SFN typically begins to produce symptoms in
adulthood, redness of the skin in the hands began at age
10, and distal limb pain began a few years later in the
proband carrying the G856D mutation; on the basis of
this history and the presence of acromesomelia (small
distal limbs), Hoeijmakers et al.9 suggested that dysfunc-
tion in peripheral axons expressing G856D mutant chan-
nels may have begun early in development. In this
respect, the results in the present study mimic the rela-
tively early onset and progression of SFN associated
with the G856D mutation in humans and may provide
an in vitro model of time-dependent axonal injury with a
compressed time-course.
G856D mutant channels are notable in displaying a
markedly enhanced persistent current,9 which would be
expected to result in a sustained Naþ inﬂux into the
neurites. In early studies on rat optic nerve, Stys
et al.16 demonstrated that, under conditions of metabolic
stress, persistent Naþ inﬂux through incompletely inacti-
vating sodium channels can lead to reverse operation of
the NCX, thereby importing damaging levels of Ca2þ.
NCX and Nav1.7 channels have previously been shown
to be expressed along the entire lengths of cultured DRG
neuronal neuritis.28 In our in vitro system, intracellular
[Ca2þ]i levels at three days in culture were similar for WT
and G856D-expressing neurites, both for smaller diam-
eter (<3 mm) and larger diameter (>5 mm) neurites. At 30
days in culture, smaller diameter G856D-expressing
neurites displayed signiﬁcantly increased [Ca2þ]i com-
pared to WT-expressing neurites, suggesting that
increased Naþ inﬂux through G856D channels triggered
reverse operation of NCX that resulted in increased
[Ca2þ]i. Consistent with this view, G856D-expressing
neurites at 18 days in culture were shown to exhibit sub-
stantially greater basal levels of [Ca2þ]i than WT Nav1.7-
expressing neurites, and inhibition of reverse mode NCX
decreased basal intracellular [Ca2þ] in G856D-expressing
neuritis.15 Larger diameter neurites did not exhibit the
diﬀerential levels of [Ca2þ]i exhibited by small-diameter
WT and G856D-expressing neurites, suggesting more
robust [Ca2þ]i diﬀusion or homeostatic mechanisms in
larger diameter neurites compared to smaller diameter
neurites.
The increased levels of [Ca2þ]i in small-diameter neur-
ites expressing G856D channels would be expected to
have adverse consequences for neurite integrity.
Increased intracellular levels of Ca2þ have been linked
to the onset of degradative cascades leading to axonal
Figure 5. Continued
point to untransfected neurites with high CM-H2DCFDA fluorescence, and arrows point to degenerating transfected neurites with high
CM-H2DCFDA fluorescence. Note the increased frequency of neurites with high fluorescence intensity for CM-H2DCFDA at 30 days in
culture that express G856D Nav1.7 compared to neurites that express WT channels at 30 days, or to WTand G856D transfected neurites
at three days in culture. (b) Histogram showing the average values for CM-H2DCFDA fluorescence at 3 days, 15 days, and 30 days in vitro
of thin (<3.0 mm) and thick (>5.0 mm) neurites. Average values of CM-H2DCFDA are not significantly different between WT and G856D
expressing neurites at 3 days and 15 days in vitro for either thin or thick neurites. In contrast, at 30 days in culture, average fluorescent
levels for both thin and thick neurites expressing G856D are significantly higher than that for neurites expressing WT Nav1.7.
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degeneration.29,30 In addition to elevated levels of intra-
cellular [Ca2þ] activating Ca2þ-sensitive calpains and
phospholipases, Ca2þ levels play a key role in mitochon-
drial function, including mobility and production of
ATP and ROS. Diﬀerential sensitivity of small-diameter
axons to gain-of-function mutations of sodium channels
is not entirely unexpected. Intracellular ionic concentra-
tions within small-diameter unmyelinated axons would
be anticipated to be particularly vulnerable to perturb-
ations caused by ion channel activity, due to their
high surface-to-volume ratios, high input impedance,
and short diﬀusional and electrotonic length constant,
and thus would be predicted to require substantial activ-
ity of the Naþ/Kþ-ATPase to maintain ionic
gradients.19,20
Our observations demonstrated reduced levels of ATP
and increased levels of ROS in neurites expressing
G856D channels. There was a time-dependent decrease
in ATP (increased MgGreen ﬂuorescence) and increase
in ROS in G856D-expressing neurites compared to WT-
expressing neurites. Interestingly, a syndrome of burning
feet/burning hands has been described in human subjects
with chronic mountain syndrome living at altitudes of
>4000m.31 The magnitude of these symptoms, which
are similar to those in SFN, was inversely correlated
with levels of Naþ/Kþ-ATPase measured in sural nerve
biopsies.32 Persson et al.21 showed that sodium channel
blockade attenuated the degeneration of neurites of
DRG neurons induced with the ATPase inhibitor oua-
bain and demonstrated a similar protective eﬀect with
blockade of reverse sodium-calcium exchange, providing
a mechanistic link between sodium channel activity,
reverse sodium-calcium exchange, and axon injury due
to run-down of ATPase.
Taken together, our observations support the notion
that the presence of G856D Nav1.7 channels places an
accumulating burden on DRG neurite integrity.
Enhanced Naþ inﬂux through G856D channels is likely
to exert two major eﬀects: (1) an increased demand for
Naþ/Kþ-ATPase activity to maintain ionic gradients in
neurites and (2) a reversal of NCX with import of Ca2þ
leading to sustained elevated levels of [Ca2þ]i. In both
cases, demand for energy supplies would be anticipated
to increase. Particularly in smaller diameter neurites,
with increasing time, rising [Ca2þ]i levels might trigger
mitochondrial dysfunction, further compounding a time-
dependent increase in intracellular calcium levels that
could enhance activity in degradative pathways and cul-
minate in neurite degeneration with a predilection for
small-diameter nerve ﬁbers.
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